IN-US-276-1340: Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women: A Demonstration Project
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The overall aim of this study is to assess attitudes toward PrEP, feasibility of Truvada PrEP
procurement through the established access procedures, and adherence to Truvada PrEP among US
women at risk for HIV acquisition.
Phase:
Phase 4
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir